SCHEMBL5608912

SCHEMBL5608912

COc1ccc(Nc2ccc(C(C)(C)C)cc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.71
GAA P10253 5/20 0.71
RAB9A P51151 5/20 0.71
MAPK1 P28482 4/20 0.71
L3MBTL1 Q9Y468 4/20 0.71
TDP1 Q9NUW8 3/20 0.71
NPC1 O15118 3/20 0.71
RECQL P46063 2/20 0.71
KDM4E B2RXH2 2/20 0.71
THRB P10828 1/20 0.71
NPSR1 Q6W5P4 1/20 0.71
NR4A1 P22736 1/20 0.59
AKR1C3 P42330 1/20 0.56
AKR1C2 P52895 1/20 0.56
ALDH1A1 P00352 4/20 0.56
LMNA P02545 3/20 0.56
ALOX15 P16050 1/20 0.56
APEX1 P27695 1/20 0.56
HSD17B10 Q99714 1/20 0.56
TRPV1 Q8NER1 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6889056 0.88 MAPT (0.58) MAPTGAARAB9AMAPK1L3MBTL1
SCHEMBL3665016 0.87 MAPT (0.64) MAPTGAARAB9AMAPK1L3MBTL1
SCHEMBL78643 0.87 MAPT (0.64) MAPTGAARAB9AMAPK1L3MBTL1
Fluoride SCHEMBL31538992 0.84 MAPT (0.62) MAPTGAARAB9AMAPK1L3MBTL1
SCHEMBL39057 0.84 MAPT (1.00) MAPTGAARAB9AMAPK1L3MBTL1
SCHEMBL2392625 0.84 TSHR (0.52) MAPTRAB9AMAPK1L3MBTL1TDP1
SCHEMBL1459772 0.84 MAPT (1.00) MAPTGAARAB9AMAPK1L3MBTL1
SCHEMBL49741 0.84 TSHR (0.52) MAPTRAB9AMAPK1L3MBTL1TDP1
SCHEMBL15603530 0.82 RAB9A (0.57) MAPTGAARAB9AMAPK1L3MBTL1
SCHEMBL21490327 0.82 MAPT (0.67) MAPTGAARAB9AMAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11793070-B2 Compound for organic electronic element, organic electronic element using the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-10-17 US disclosed
US-11793070-B2 Compound for organic electronic element, organic electronic element using the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-10-17 US disclosed
US-10991888-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device DUK SAN NEOLUX CO., LTD. (KR) 2021-04-27 US disclosed
US-20210063411-A1 DETECTING TARGETS USING MASS TAGS AND MASS SPECTROMETRY VENTANA MED SYST INC (US) 2021-03-04 US disclosed
US-10883999-B2 Detecting targets using mass tags and mass spectrometry VENTANA MEDICAL SYSTEMS, INC. (US) 2021-01-05 US disclosed
US-10428084-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2019-10-01 US disclosed
US-10333073-B2 Compound for organic electric element, organic electric element using the same, and electronic device comprising same DUK SAN NEOLUX CO., LTD. (KR) 2019-06-25 US disclosed
US-10319916-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device DUK SAN NEOLUX CO., LTD. (KR) 2019-06-11 US disclosed
US-10283716-B2 Compound for organic electric element, organic electric element using the same, and electronic device comprising same DUK SAN NEOLUX CO., LTD. (KR) 2019-05-07 US disclosed
US-20190051837-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE DUK SAN NEOLUX CO., LTD. (KR) 2019-02-14 US disclosed
US-7557110-B2 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine TEIJIN PHARMA LIMITED (JP) 2009-07-07 US disclosed
US-7541462-B2 Triaminophosphine ligands for carbon-nitrogen and carbon-carbon bond formation IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2009-06-02 US disclosed
US-20080139806-A1 TRIAMINOPHOSPHINE LIGANDS FOR CARBON-NITROGEN AND CARBON-CARBON BOND FORMATION IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.. 2008-06-12 US disclosed
US-7385058-B1 Triaminophosphine ligands for carbon-nitrogen and carbon-carbon bond formation IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2008-06-10 US disclosed
EP-1354887-B1 Ligands for metals and improved metal-catalyzed processes based thereon MASSACHUSETTS INST TECHNOLOGY (US) 2007-04-25 EP disclosed
EP-1097158-B1 LIGANDS FOR METALS AND METAL-CATALYZED PROCESSES MASSACHUSETTS INST TECHNOLOGY (US) 2006-01-25 EP disclosed
US-6888029-B2 Transition-metal-catalyzed carbon-nitrogen bond-forming methods using carbene ligands MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2005-05-03 US disclosed
US-20040044250-A1 Transition-metal-catalyzed carbon-nitrogen bond-forming methods using carbene ligands NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-03-04 US disclosed
EP-1354887-A1 Ligands for metals and improved metal-catalyzed processes based thereon Massachusetts Insitute of Technology (US) 2003-10-22 EP disclosed
WO-2003066570-A1 TRANSITION-METAL-CATALYZED CARBON-NITROGEN BOND-FORMING METHODS USING CARBENE LIGANDS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2003-08-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10991888-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device NFE2L2, LAGE3, OR51E2 MAPT 1557/4885GAA 1336/4885RAB9A 2894/4885
US-11793070-B2 Compound for organic electronic element, organic electronic element using the same, and electronic device thereof OR51E2, ETV6, OR10J3 MAPT 1409/4885GAA 1555/4885RAB9A 3246/4885
US-20080139806-A1 TRIAMINOPHOSPHINE LIGANDS FOR CARBON-NITROGEN AND CARBON-CARBON BOND FORMATION ABL1, AOC1, NPPA MAPT 3909/4885GAA 2878/4885RAB9A 655/4885
US-10283716-B2 Compound for organic electric element, organic electric element using the same, and electronic device comprising same EBPL, OR51E2, EML4 MAPT 1604/4885GAA 2101/4885RAB9A 3704/4885
US-10319916-B2 Compound for organic electronic element, organic electronic element using the same, and an electronic device NFE2L2, LAGE3, EMC2 MAPT 1389/4885GAA 1487/4885RAB9A 2862/4885
US-10333073-B2 Compound for organic electric element, organic electric element using the same, and electronic device comprising same EBPL, OR51E2, EML4 MAPT 1604/4885GAA 2101/4885RAB9A 3704/4885
US-10428084-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof PIEZO1, OCIAD1, LEF1 MAPT 2905/4885GAA 3302/4885RAB9A 3228/4885
US-20190051837-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE NFE2L2, LAGE3, EMC2 MAPT 1389/4885GAA 1487/4885RAB9A 2862/4885
US-20040044250-A1 Transition-metal-catalyzed carbon-nitrogen bond-forming methods using carbene ligands PAM, DAO, NAA15 MAPT 1076/4885GAA 2004/4885RAB9A 1090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.